Akebia Therapeutics Inc (AKBA)
1.40
+0.09
(+6.87%)
USD |
NASDAQ |
May 03, 14:17
Akebia Therapeutics Shares Outstanding: 209.60M for April 9, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 09, 2024 | 209.60M |
March 31, 2024 | 209.45M |
March 13, 2024 | 209.37M |
December 31, 2023 | 194.58M |
November 06, 2023 | 188.39M |
September 30, 2023 | 188.31M |
August 25, 2023 | 188.31M |
June 30, 2023 | 188.13M |
April 30, 2023 | 185.93M |
April 18, 2023 | 185.93M |
March 31, 2023 | 185.84M |
February 28, 2023 | 184.25M |
February 16, 2023 | 184.25M |
January 31, 2023 | 184.25M |
December 31, 2022 | 184.14M |
October 31, 2022 | 183.96M |
September 30, 2022 | 183.95M |
July 31, 2022 | 183.85M |
June 30, 2022 | 183.70M |
April 30, 2022 | 183.53M |
April 11, 2022 | 183.53M |
March 31, 2022 | 183.39M |
February 23, 2022 | 181.23M |
December 31, 2021 | 177.00M |
October 31, 2021 | 174.96M |
Date | Value |
---|---|
September 30, 2021 | 174.55M |
July 30, 2021 | 174.54M |
June 30, 2021 | 169.65M |
April 30, 2021 | 160.12M |
April 12, 2021 | 159.91M |
March 31, 2021 | 158.52M |
February 19, 2021 | 153.50M |
December 31, 2020 | 148.07M |
October 30, 2020 | 144.54M |
September 30, 2020 | 143.33M |
July 31, 2020 | 143.32M |
June 30, 2020 | 143.13M |
May 14, 2020 | 142.92M |
April 30, 2020 | 130.27M |
April 15, 2020 | 130.27M |
April 09, 2020 | 130.27M |
March 31, 2020 | 130.25M |
March 01, 2020 | 129.86M |
December 31, 2019 | 121.67M |
October 31, 2019 | 118.94M |
September 30, 2019 | 118.86M |
July 31, 2019 | 118.86M |
June 30, 2019 | 118.79M |
April 30, 2019 | 117.86M |
April 12, 2019 | 117.74M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
118.79M
Minimum
Jun 30 2019
209.60M
Maximum
Apr 09 2024
165.71M
Average
175.98M
Median
Shares Outstanding Benchmarks
Ocugen Inc | 257.33M |
Aquestive Therapeutics Inc | 73.30M |
SELLAS Life Sciences Group Inc | 56.27M |
Protagonist Therapeutics Inc | 58.28M |
Stoke Therapeutics Inc | 46.30M |